CUMP75: Terrorist Attack - Continuity of Care

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT03770156
Collaborator
(none)
14
1
9
1.6

Study Details

Study Description

Brief Summary

On November 13th 2015, a terrorist attack killed 129 victims in Paris. An emergency crisis unit (CUMP) has been activated in Paris in the days following the attack and a subunit was in charge to answer to the phone calls of victims and their relatives. The same emergency crisis unit have been activated for the terrorist attack in London, 2017 june 3, terrorist attack in Barcelone 2017 august 17-18, terrorist attack in Strasbourg 2018 December 11 The purpose of this observational study is to document the evolution of psychiatric symptoms among subjects who called the CUMP and to collect information about the type of medical or non-medical care they were seeking for.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Questionnaires

Detailed Description

The care of the victims of natural disasters or mass disasters such as terrorist attacks is now better structured and organized. The efficacy of debriefing or of defusing has been and is still debated, sometimes bitterly. The aim of the present study is not to demonstrate utility or futility of such approaches, but to i) evaluate their global improvement over the past three years. ii) to list the type of support that the victims were seeking in their attempt to get rid of the symptoms which appeared after the terrorist attack of November 2015 in Paris.

  1. to collect their opinions about the way the CUMP (emergency medico-psychological unit of Paris, France) managed the support to the victims.

Participating subjects registered on the occasion of their first contact with the CUMP 75 by phone during the week following the attack

Study Design

Study Type:
Observational
Actual Enrollment :
14 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Attentats - Continuité Des Soins
Actual Study Start Date :
Jan 22, 2020
Actual Primary Completion Date :
Oct 22, 2020
Actual Study Completion Date :
Oct 22, 2020

Arms and Interventions

Arm Intervention/Treatment
Subjects who contacted CUMP by phone

Subjects who contacted CUMP (Medical Psychological Emergency Cell) by phone from Paris November 13th, 2015, London 11th,2017 ; Barcelone 17-18th, 2017 ; Strasbourg 11th, 2018.

Behavioral: Questionnaires
Overall Impression of the current state and evolution since the attacks

Outcome Measures

Primary Outcome Measures

  1. Clinical Global Impression - Improvement scale (CGI-I) [One day]

    Self-assessment of improvement or aggravation

Secondary Outcome Measures

  1. Clinical Global Impression - Severity scale (CGI-S) [One day]

    Self-assessment of symptom severity

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All subjects who called the CUMP of Paris between November 13th, 2015 and January 31st, 2016; London 11th,2017 ; Barcelone 17-18th, 2017 ; Strasbourg 11th, 2018 and completed the questionnaire.
Exclusion Criteria:
  • Subjects who did not consent to their participation to the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CUMP Paris Paris France 75015

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Gaëlle ABGRALL-BARBRY, MD, Assistance Publique - Hôpitaux de Paris
  • Study Chair: Gaëlle ABGRALL-BARBRY, MD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT03770156
Other Study ID Numbers:
  • NI18012J
  • 2017-A01382-51
First Posted:
Dec 10, 2018
Last Update Posted:
Sep 23, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2021